Clinical Trials Browser

Thyroid Neoplasms × anlotinib × 90 days × Clear all

NCT07193186 2026-02-27

Anlotinib and Benmelstobart in DTC

Phase 2 Not yet recruiting

Thyroid Neoplasms

NCT07419932 2026-02-19

NeoLATC

Thyroid Neoplasms